PopulationsHumans49,796 participants10 yearsCohort studyDeclared ties to: ONL Therapeutics, Sumitomo Pharma, Drusolv Therapeutics and 16 more

Sustained proton-pump inhibitor exposure and incident age-related macular degeneration: a new-user, population-based cohort study

Figure 1. Cumulative incidence of AMD and death over 10 years after the landmark date among sustained PPI exposed participants and matched unexposed controls.
Open the figure at full size
Figure 1. Cumulative incidence of AMD and death over 10 years after the landmark date among sustained PPI exposed participants and matched unexposed controls.Cumulative incidence of AMD and death over 10 years after the landmark date among sustained PPI exposed participants and matched unexposed controls.Bantounou et al.

BMJ Open Ophthalmology

The paper

Massachusetts Eye and Ear Infirmary

BMJ Open Ophthalmology · 23 Sep 2026

doi.org/10.1136/bmjophth-2026-002935PubMed 42778294

More on Age-related macular degeneration